000			01581 a2200469 4500
005			20250511125314.0
264		0	_c19791024
008			197910s 0 0 eng d
022			_a0098-1532
024	7		_a10.1002/mpo.2950060306 _2doi
040			_aNLM _beng _cNLM
100	1		_aPerez, C
245	0	0	_aEvaluation of overall toxicity of high-dosage methotrexate regimens. _h[electronic resource]
260			_bMedical and pediatric oncology _c1979
300			_a219-28 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdolescent
650	0	4	_aAge Factors
650	0	4	_aBone Marrow _xdrug effects
650	0	4	_aBone Neoplasms _xdrug therapy
650	0	4	_aChild
650	0	4	_aDermatitis _xchemically induced
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aKidney _xdrug effects
650	0	4	_aLeucovorin _xadministration & dosage
650	0	4	_aLeukopenia _xchemically induced
650	0	4	_aLiver _xdrug effects
650	0	4	_aMale
650	0	4	_aMethotrexate _xadverse effects
650	0	4	_aOsteosarcoma _xdrug therapy
650	0	4	_aSex Factors
650	0	4	_aStomatitis _xchemically induced
650	0	4	_aThrombocytopenia _xchemically induced
650	0	4	_aVincristine _xadministration & dosage
700	1		_aSutow, W W
700	1		_aWang, Y M
700	1		_aHerson, J
773	0		_tMedical and pediatric oncology _gvol. 6 _gno. 3 _gp. 219-28
856	4	0	_uhttps://doi.org/10.1002/mpo.2950060306 _zAvailable from publisher's website
999			_c339288 _d339288